Urinary excretion of homocysteine thiolactone and the risk of acute myocardial infarction in coronary artery disease patients: the WENBIT trial

OBJECTIVES: No individual homocysteine (Hcy) metabolite has been studied as a risk marker for coronary artery disease (CAD). Our objective was to examine Hcy‐thiolactone, a chemically reactive metabolite generated by methionyl‐tRNA synthetase and cleared by the kidney, as a risk predictor of inciden...

Descripción completa

Detalles Bibliográficos
Autores principales: Borowczyk, K., Piechocka, J., Głowacki, R., Dhar, I., Midtun, Ø., Tell, G. S., Ueland, P. M., Nygård, O., Jakubowski, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378604/
https://www.ncbi.nlm.nih.gov/pubmed/30193001
http://dx.doi.org/10.1111/joim.12834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378604/
https://www.ncbi.nlm.nih.gov/pubmed/30193001
http://dx.doi.org/10.1111/joim.12834

Ejemplares similares